Nine Monthly Results Results Snapshot
Figures in Cr
No Consolidated Results Declared by Dipna Pharmachem
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Mar 2026 is -19.74% vs 21.81% in Mar 2026
Standalone Net Profit
YoY Growth in nine months ended Mar 2026 is 205.77% vs -32.47% in Mar 2026
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Mar 2026 is 75.00% vs -9.86% in Mar 2026
Interest
YoY Growth in nine months ended Mar 2026 is -1.60% vs 13.64% in Mar 2026
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Mar 2026 has improved from Mar 2026
Compare Nine Monthly Results Of Dipna Pharmachem With
Figures in Cr
No Consolidated Results Declared by Dipna Pharmachem
Nine Monthly - Net Sales
Net Sales 74.35 Cr
in Mar 2026Figures in Cr
YoY Growth in nine months ended Mar 2026 is -19.74% vs 21.81% in Mar 2026
Nine Monthly - Standalone Net Profit
Standalone Net Profit 1.59 Cr
in Mar 2026Figures in Cr
YoY Growth in nine months ended Mar 2026 is 205.77% vs -32.47% in Mar 2026
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.36 Cr
in Mar 2026Figures in Cr
YoY Growth in nine months ended Mar 2026 is 75.00% vs -9.86% in Mar 2026
Nine Monthly - Interest
Interest 1.23 Cr
in Mar 2026Figures in Cr
YoY Growth in nine months ended Mar 2026 is -1.60% vs 13.64% in Mar 2026
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.45%
in Mar 2026Figures in %
YoY Growth in nine months ended Mar 2026 has improved from Mar 2026
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
